Form 8-K - Current report:
SEC Accession No. 0001193125-22-247108
Filing Date
2022-09-19
Accepted
2022-09-19 16:17:02
Documents
16
Period of Report
2022-09-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382258d8k.htm   iXBRL 8-K 28816
2 EX-1.1 d382258dex11.htm EX-1.1 203064
3 EX-5.1 d382258dex51.htm EX-5.1 13800
7 GRAPHIC g382258dsp00.jpg GRAPHIC 5228
8 GRAPHIC g382258dsp2.jpg GRAPHIC 6660
  Complete submission text file 0001193125-22-247108.txt   445963

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idya-20220914.xsd EX-101.SCH 2864
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20220914_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20220914_pre.xml EX-101.PRE 11713
10 EXTRACTED XBRL INSTANCE DOCUMENT d382258d8k_htm.xml XML 3531
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 221250808
SIC: 2834 Pharmaceutical Preparations